Questions about OTC or prescription medications while pregnant or nursing?
Call our experts.
Monday – Friday, 8am – 5pm CT
1 (806) 352-2519
The fast-acting nasal spray esketamine, marketed as SpravatoTM, was recently approved by the Food and Drug Administration (FDA) to treat depression in individuals whose depression has been resistant to at least two medications.
As cold and flu season swings into full effect, runny noses, coughing, and body aches leave many breastfeeding mothers wondering whether some quick relief from over-the-counter medications could negatively impact their breastfeeding baby. Research shows that some cold and flu medications are better than others when it comes to breastfeeding.
Zika virus is a flavivirus transmitted by the Aedes mosquitoes. Only 20% of adults infected will have clinical manifestations such as low-grade fevers, itchy rash, joint pain in the hands and feet, and eye inflammation. Current outbreaks are in the Americas, Caribbean, and Pacific, but cases have been seen around the world.
Nexplanon has become a very popular contraceptive method in recent years because it lasts for 3 years and you do not have to take a pill every day. While the idea of an implant under the skin is daunting, many still prefer it over IUD insertion or taking oral contraceptive pills every day.
When looking at the research for IUD insertion, we first must ask “what type of IUD are you interested in?”. Copper IUDs (ParaGuard), do not release any hormones and thus do not affect breast milk production. The copper IUDs last for 10-12 years depending on your age and are made of a polyethylene frame with fine copper wire wrapped around it.
Legalization of recreational cannabis use in several states has caused growing unease in the medical community regarding the health risks associated with this drug, especially in pregnant and breastfeeding women. Although cannabis is one of the most widely used phytocannabinoid drugs in the world, understanding of the long-term neurobehavioral effect of cannabis use, particularly in the...
About the InfantRisk Center Team
Thomas Hale, Ph.D., R.Ph., is a professor of pediatrics and associate dean of research at Texas Tech University Health Sciences Center and acting executive director of the InfantRisk Center.
Hale is considered one of the foremost expert in the field of perinatal pharmacology and the use of medications by pregnant and breastfeeding mothers.
The vision of the InfantRisk Center is to create a new body of drug information concerning the safety of medications and their use during pregnancy and lactation. Additionally, the center will expand, enhance and disseminate knowledge regarding the use of medications and other environmental chemicals by pregnant and breastfeeding women worldwide.
Dr. Baker graduated from the University of Texas Southwestern and completed her residency training at Parkland Health and Hospital System in Dallas, TX. She is Board Certified by the American Board of Obstetrics and Gynecology and is a Fellow of the American College of Obstetricians and Gynecologists.
Dr. Baker has a combined private and academic OB/GYN practice with the University Physicians at Texas Tech Health Sciences Center in Amarillo. She is interested in teen pregnancy, postpartum depression, and promoting preventive medicine for the women of the Texas Panhandle, as well as Resident and Student education and serves as the Residency Director.